CLOVIS ONCOLOGY INC CLVS 4.5 08.01.24
NOTE 4.500% 8/0 · US DOMESTIC · CUSIP 189464AE0
8
institutional holders
-1 vs Q4 2021
$77.5mprincipal reported held*
$53.8mreported value*
0 new
0 added
1 reduced
1 sold out
net sold ≈ $5.7m
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2020 | 14 |
| Q4 2020 | 13 |
| Q1 2021 | 12 |
| Q2 2021 | 11 |
| Q3 2021 | 10 |
| Q4 2021 | 9 |
| Q1 2022 | 8 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2020 | 1 | 2 |
| Q1 2021 | 1 | 3 |
| Q2 2021 | 1 | 2 |
| Q3 2021 | 5 | 4 |
| Q4 2021 | 3 | 2 |
| Q1 2022 | 0 | 2 |
Biggest buyers
| None |
Biggest sellers
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | Sold out | -4.5m |
| WOLVERINE ASSET MANAGEMENT LLC | Reduced | -3.8m |
Holders, Q1 2022
| Manager | Shares | Change |
|---|---|---|
| ARISTEIA CAPITAL, L.L.C. 0.32% of their portfolio | 24.1m $17.8m | Unchanged |
| QVT Financial LP 0.62% of their portfolio | 20.0m $14.1m | Unchanged |
| LMR Partners LLP 0.10% of their portfolio | 13.1m $8.3m | Unchanged |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC 0.19% of their portfolio | 10.9m $7.2m | Unchanged |
| CAPSTONE INVESTMENT ADVISORS, LLC 0.11% of their portfolio | 7.1m $4.9m | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 2.0m $1.3m | Unchanged |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 250.0k $185.0k | Reduced -3.8m |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |